Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Counting Costs under Severe Financial Constraints: A Cost-of-Illness Analysis of Spondyloarthropathies in a Tertiary Hospital in Greece.

Tsifetaki N, Migkos MP, Papagoras C, Voulgari PV, Athanasakis K, Drosos AA.

J Rheumatol. 2015 Jun;42(6):963-7. doi: 10.3899/jrheum.141277. Epub 2015 Apr 1.

PMID:
25834213
2.

Sense of coherence and self-sacrificing defense style as predictors of psychological distress and quality of life in rheumatoid arthritis: a 5-year prospective study.

Goulia P, Voulgari PV, Tsifetaki N, Andreoulakis E, Drosos AA, Carvalho AF, Hyphantis T.

Rheumatol Int. 2015 Apr;35(4):691-700. doi: 10.1007/s00296-014-3134-8. Epub 2014 Sep 21.

PMID:
25240430
3.

Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study.

Papagoras C, Achenbach K, Tsifetaki N, Tsiouris S, Fotopoulos A, Drosos AA.

Clin Rheumatol. 2014 Aug;33(8):1105-11. doi: 10.1007/s10067-014-2666-3. Epub 2014 May 22.

PMID:
24847773
4.

Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.

Kotsis K, Voulgari PV, Tsifetaki N, Drosos AA, Carvalho AF, Hyphantis T.

Rheumatol Int. 2014 Dec;34(12):1671-81. doi: 10.1007/s00296-014-3008-0. Epub 2014 Apr 27.

PMID:
24769916
5.

White matter water diffusion changes in primary Sjögren syndrome.

Tzarouchi LC, Zikou AK, Tsifetaki N, Astrakas LG, Konitsiotis S, Voulgari P, Drosos A, Argyropoulou MI.

AJNR Am J Neuroradiol. 2014 Apr;35(4):680-5. doi: 10.3174/ajnr.A3756. Epub 2013 Nov 1.

6.

The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Hyphantis T, Kotsis K, Tsifetaki N, Creed F, Drosos AA, Carvalho AF, Voulgari PV.

Clin Rheumatol. 2013 May;32(5):635-44. doi: 10.1007/s10067-012-2162-6. Epub 2013 Jan 18.

PMID:
23329349
7.

Adult-onset Still's disease: clinical, serological and therapeutic considerations.

Iliou C, Papagoras C, Tsifetaki N, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):47-52. Epub 2012 Sep 25.

PMID:
23010097
8.

Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life.

Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T.

Arthritis Care Res (Hoboken). 2012 Oct;64(10):1593-601. doi: 10.1002/acr.21725.

9.

CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry.

Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, Argyropoulou MI.

AJR Am J Roentgenol. 2011 Nov;197(5):1207-12. doi: 10.2214/AJR.10.5984.

PMID:
22021516
10.

Clinical images: Corneal melt in a woman with longstanding rheumatoid arthritis.

Iliou C, Anthis N, Tsifetaki N, Kitsos G, Voulgari PV.

Arthritis Rheum. 2012 Jan;64(1):253. doi: 10.1002/art.33389. No abstract available.

11.

The psychological defensive profile of primary Sjögren's syndrome patients and its relationship to health-related quality of life.

Hyphantis T, Mantis D, Voulgari PV, Tsifetaki N, Drosos AA.

Clin Exp Rheumatol. 2011 May-Jun;29(3):485-93. Epub 2011 Jun 29.

PMID:
21640041
12.

Diagnostic accuracy, internal consistency, and convergent validity of the Greek version of the patient health questionnaire 9 in diagnosing depression in rheumatologic disorders.

Hyphantis T, Kotsis K, Voulgari PV, Tsifetaki N, Creed F, Drosos AA.

Arthritis Care Res (Hoboken). 2011 Sep;63(9):1313-21. doi: 10.1002/acr.20505.

13.

Coping with health-stressors and defence styles associated with health-related quality of life in patients with systemic lupus erythematosus.

Hyphantis T, Palieraki K, Voulgari PV, Tsifetaki N, Drosos AA.

Lupus. 2011 Aug;20(9):893-903. doi: 10.1177/0961203311398264. Epub 2011 May 11.

PMID:
21562019
14.

Comparison of health-related quality of life and associated psychological factors between younger and older patients with established rheumatic disorders.

Goulia P, Voulgari PV, Tsifetaki N, Drosos AA, Hyphantis T.

Aging Ment Health. 2010 Sep;14(7):819-27. doi: 10.1080/13607861003781809.

PMID:
20635230
15.

Subclinical atherosclerosis in scleroderma patients.

Tsifetaki N, Georgiadis AN, Alamanos Y, Fanis S, Argyropoulou MI, Drosos AA.

Scand J Rheumatol. 2010 Aug;39(4):326-9. doi: 10.3109/03009741003605648.

PMID:
20476856
16.

Images in rheumatology. Transfusion-related acute lung injury during intravenous immunoglobulin treatment.

Voulgari PV, Paschou S, Svarna E, Tsifetaki N, Drosos AA.

J Rheumatol. 2010 Jan;37(1):190-1. doi: 10.3899/jrheum.090725. No abstract available.

PMID:
20040637
17.

The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis.

Bai M, Tomenson B, Creed F, Mantis D, Tsifetaki N, Voulgari PV, Drosos AA, Hyphantis TN.

Scand J Rheumatol. 2009 Nov-Dec;38(6):419-30. doi: 10.3109/03009740903015135.

PMID:
19922016
18.

Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders.

Hyphantis T, Tomenson B, Paika V, Almyroudi A, Pappa C, Tsifetaki N, Voulgari PV, Drosos AA, Pavlidis N, Creed F.

Qual Life Res. 2009 Oct;18(8):1029-42. doi: 10.1007/s11136-009-9527-6. Epub 2009 Aug 22.

PMID:
19701696
19.

Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.

Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA.

J Rheumatol. 2009 Jul;36(7):1550-2. doi: 10.3899/jrheum.080992. No abstract available.

PMID:
19567637
20.

Ankylosing spondylitis and IgA deficiency.

Stergiouli I, Tsifetaki N, Voulgari PV, Kosta P, Argyropoulou MI, Drosos AA.

Joint Bone Spine. 2009 Jan;76(1):110-1. doi: 10.1016/j.jbspin.2008.05.007. Epub 2008 Nov 6. No abstract available.

PMID:
18993105
21.

Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study.

Voulgari PV, Venetsanopoulou AI, Exarchou SA, Alamanos Y, Tsifetaki N, Drosos AA.

Semin Arthritis Rheum. 2008 Apr;37(5):293-8. Epub 2007 Sep 21.

PMID:
17888499
22.

Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.

Pelidou SH, Giannopoulos S, Tzavidi S, Tsifetaki N, Kitsos G, Stefanou D, Kostadima V, Drosos AA, Kyritsis AP.

Rheumatol Int. 2007 Nov;28(1):15-20. Epub 2007 Jun 15.

PMID:
17571265
23.

Glaucomatous type abnormalities in patients with systemic sclerosis.

Kitsos G, Tsifetaki N, Gorezis S, Drosos AA.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):341. No abstract available.

PMID:
17543168
24.

The impact of psychological functioning upon systemic sclerosis patients' quality of life.

Hyphantis TN, Tsifetaki N, Siafaka V, Voulgari PV, Pappa C, Bai M, Palieraki K, Venetsanopoulou A, Mavreas V, Drosos AA.

Semin Arthritis Rheum. 2007 Oct;37(2):81-92. Epub 2007 May 21.

PMID:
17512572
25.

Clinical features and personality traits associated with psychological distress in systemic sclerosis patients.

Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V.

J Psychosom Res. 2007 Jan;62(1):47-56.

PMID:
17188120
26.

Multiple sclerosis associated with systemic sclerosis.

Pelidou SH, Tsifetaki N, Giannopoulos S, Deretzi G, Voulgari P, Kyritsis A.

Rheumatol Int. 2007 Jun;27(8):771-3. Epub 2006 Dec 14.

PMID:
17171345
27.

Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.

Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA.

Semin Arthritis Rheum. 2006 Dec;36(3):173-81. Epub 2006 Oct 11. Review.

PMID:
17045629
28.

Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging.

Argyropoulou MI, Tsifetaki N, Zikou AK, Xydis V, Venestanopoulou AI, Margariti P, Drosos AA.

Arthritis Rheum. 2006 Apr;54(4):1350-2. No abstract available.

29.

Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?

Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA.

Clin Exp Rheumatol. 2005 Nov-Dec;23(6):861-6.

PMID:
16396705
30.

Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.

Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA.

Rheumatology (Oxford). 2006 Feb;45(2):187-91. Epub 2005 Dec 6. Review.

PMID:
16332955
31.

Magnetic resonance imaging findings of the cervical spine in patients with rheumatoid arthritis. A cross-sectional study.

Zikou AK, Argyropoulou MI, Alamanos Y, Tsifetaki N, Tsampoulas C, Voulgari PV, Efremidis SC, Drosos AA.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):665-70.

PMID:
16173243
32.

A single pulmonary rheumatoid nodule masquerading as malignancy.

Voulgari PV, Tsifetaki N, Metafratzi ZM, Zioga A, Acritidis NC, Drosos AA.

Clin Rheumatol. 2005 Sep;24(5):556-9. Epub 2005 May 21.

PMID:
15909073
33.

Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study.

Zikou AK, Alamanos Y, Argyropoulou MI, Tsifetaki N, Tsampoulas C, Voulgari PV, Efremidis SC, Drosos AA.

J Rheumatol. 2005 May;32(5):801-6.

PMID:
15868612
34.

Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.

Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, Drosos AA.

Semin Arthritis Rheum. 2005 Apr;34(5):714-20.

PMID:
15846586
35.

Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.

Tsifetaki N, Kitsos G, Paschides CA, Alamanos Y, Eftaxias V, Voulgari PV, Psilas K, Drosos AA.

Ann Rheum Dis. 2003 Dec;62(12):1204-7.

36.

Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.

Papadopoulos NG, Alamanos Y, Papadopoulos IA, Tsifetaki N, Voulgari PV, Drosos AA.

J Rheumatol. 2002 Feb;29(2):261-6.

PMID:
11838843
37.

Sicca syndrome in patients with sarcoidosis.

Drosos AA, Voulgari PV, Psychos DN, Tsifetaki N, Bai M.

Rheumatol Int. 1999;18(5-6):177-80.

PMID:
10399792
38.

Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study.

Drosos AA, Tsifetaki N, Tsiakou EK, Timpanidou M, Tsampoulas C, Tatsis CK, Kotoulas K, Moutsopoulos HM.

Clin Exp Rheumatol. 1997 May-Jun;15(3):263-7.

PMID:
9177920
39.

Subgroups of primary Sjögren's syndrome. Sjögren's syndrome in male and paediatric Greek patients.

Drosos AA, Tsiakou EK, Tsifetaki N, Politi EN, Siamopoulou-Mavridou A.

Ann Rheum Dis. 1997 May;56(5):333-5.

40.

Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

Vlachoyiannopoulos PG, Tsifetaki N, Dimitriou I, Galaris D, Papiris SA, Moutsopoulos HM.

Ann Rheum Dis. 1996 Oct;55(10):761-8.

41.

Methotrexate in primary Sjögren's syndrome.

Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM.

Clin Exp Rheumatol. 1996 Sep-Oct;14(5):555-8.

PMID:
8913659
42.

Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis.

Guialis A, Patrinou-Georgoula M, Tsifetaki N, Aidinis V, Sekeris CE, Moutsopoulos HM.

Clin Exp Immunol. 1994 Mar;95(3):385-9.

Supplemental Content

Loading ...
Support Center